BACARDI-LIMITED
15.7.2021 14:06:08 CEST | Business Wire | Press release
After decades spent pioneering sustainable practices in the vineyards of northwest Italy, MARTINI, the world’s number one Italian sparkling wine and vermouth from family-owned Bacardi, is proud to announce that all its Asti grape suppliers are on track to being certified sustainable in 2021.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210715005597/en/
The timing could not be more perfect. As Bacardi celebrates this major sustainability milestone, it’s also celebrating 150 years since Martini & Rossi produced its first samples of ‘moscato spumante d’Asti’ to meet demand from customers around the world back in 1871.
The MARTINI Santo Stefano Belbo winery, located in the heart of the Asti region and responsible for producing 30% of all the grape ‘must’ (grape juice) for MARTINI Asti, was recently certified sustainable by Equalitas, the most comprehensive sustainability standard in Italian wine making, following an audit by certification body Valoritalia. Of the remaining 70%, more than two-thirds of the grape must suppliers – cooperatives representing hundreds of small grape growers – have also been certified sustainable by Equalitas with the remainder on track to be certified this year.
Together with the recent announcement that the 10 botanicals used to create BOMBAY SAPPHIRE® will be certified sustainable in 2021, this news is another major step towards Bacardi achieving its 2025 goal of sourcing 100% of its key ingredients from sustainably certified suppliers.
It was back in 1987 that, in true pioneering style, MARTINI established a center dedicated to sustainable business practices called L'Osservatorio MARTINI – the MARTINI Observatory. Located in the heart of the region and led by a local agronomist expert in the cultivation of vineyards, L'Osservatorio MARTINI has introduced many sustainability practices to the region – from advising on natural ways to manage pests through to integrated viticulture, looking at the balance of what is grown in the microclimates of the Asti region.
“There is a deep connection between MARTINI, the land and the people – it’s a solid foundation for making quality wine,” said Giorgio Castagnotti, Director of the MARTINI Operations Center in Pessione, Italy. “We have worked closely with the same farming communities growing the finest Moscato grapes in the same beautiful hills for generations – in fact for the last 150 years – and we want to continue to do so for generations to come. It’s always made sense then for us support our grape growers through our sustainability initiatives.”
The steep, sun-drenched hills of Asti in the heart of the Piedmont region of Italy, are the ideal growing environment for the Moscato Bianco grape, and have a DOCG designation, the highest quality level for Italian wines. Expertly harvested in late summer by more than 200 small growers – known collectively as the Conferenti – the grapes are pressed quickly to capture the desired natural flavors in the fresh juice called ‘must’. Through fermentation, this ‘mosto’ becomes the basis of MARTINI Asti’s delicate flavors including notes of peach, sweet wild sage, fresh pear and pineapple.
Stefano Stefanucci, Director of Equalitas, said: “This is a big achievement for MARTINI. Equalitas only works with third-party auditors who are experts with a deep knowledge of the wine sector and the certification process is wholly holistic. Equalitas embraces three sustainability pillars – environmental, ethical and economical – and takes into consideration everything from a winery’s carbon footprint and water consumption through to fair commercial terms for farmers and good social practices including training and welfare.”
Victoria Morris, Global VP MARTINI, added: “Being a family-owned company genuinely makes a difference to the way Bacardi approaches sustainability. We are committed to doing the right thing for the environment, for our suppliers and for their communities for the long term. I am incredibly proud of Giorgio and his team. They are masters of their craft and have reached a new milestone in the long history of MARTINI. It’s the perfect way to toast 150 years of MARTINI Asti!”
Find out more about the sustainability commitments of Bacardi and its vision to become the most environmentally responsible global spirits company at https://www.bacardilimited.com/corporate-responsibility/environment/ .
Always drink responsibly.
About MARTINI
One of the most iconic brands in the world, MARTINI® is the leading name in Italian winemaking and a purveyor of the highest quality aromatized and sparkling wines. The award- winning, vibrant and bittersweet taste of the MARTINI range is the result of secret blends of more than 40 botanicals sourced from the finest locations across the globe. First created in 1863 in Turin, Italy, the MARTINI portfolio today includes: MARTINI Fiero, MARTINI Riserva Speciale Rubino, MARTINI Riserva Speciale Ambrato, MARTINI Riserva Speciale Bitter, MARTINI Bianco, MARTINI Rosato, MARTINI Rosso, MARTINI Extra Dry, MARTINI Asti, MARTINI Prosecco and MARTINI Rosé Extra Dry. For more information, please visit www.martini.com .
MARTINI and the ball & bar logo are trademarks. MARTINI is part of the portfolio of Bacardi Limited, headquartered in Hamilton, Bermuda. Bacardi Limited refers to the Bacardi group of companies, including Bacardi International Limited.
About Bacardi
Bacardi Limited, the largest privately held spirits company in the world, produces and markets internationally recognized spirits and wines. The Bacardi Limited brand portfolio comprises more than 200 brands and labels, including BACARDÍ® rum, GREY GOOSE® vodka, PATRÓN® tequila, DEWAR’S® Blended Scotch whisky, BOMBAY SAPPHIRE® gin, MARTINI® vermouth and sparkling wines, CAZADORES® 100% blue agave tequila, and other leading and emerging brands including WILLIAM LAWSON’S® Scotch whisky, ST-GERMAIN® elderflower liqueur, and ERISTOFF® vodka. Founded nearly 160 years ago in Santiago de Cuba, family-owned Bacardi Limited currently employs more than 7,000, operates production facilities in 11 countries, and sells its brands in more than 170 countries. Bacardi Limited refers to the Bacardi group of companies, including Bacardi International Limited. Visit www.bacardilimited.com or follow us on Twitter , LinkedIn or Instagram .
About Equalitas
Equalitas Srl was founded in 2015 by Federdoc ed Unione Italiana Vini, with a view to building on the technical and cultural achievements of a movement of stakeholders committed to developing wine sustainability, in support of the Forum for Wine Sustainability and the UIV-Tergeo project. The initial partnership was later completed and strengthened by the participation of CSQA Certificazioni, one of the leading agrifood certification bodies in Italy; Valoritalia, the first Wine Denomination of Origin certifying body; Gambero Rosso, Italy’s largest multimedia publisher specializing in food and wine; and 3AVino, a financial company targeting the wine-growing industry. A broad set of skills and expertise that can ensure a comprehensive and integrated approach to sustainability, from the point of view of its economic, social and environmental components. Visit www.equalitas.it .
View source version on businesswire.com: https://www.businesswire.com/news/home/20210715005597/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
